|
Test Catalog
|
|
ADmark® Early Onset Alzheimer's Evaluation |
#179 |
|
| Type of Disorder: |
Dementia |
|
| Typical Presentation: |
Progressive demential with onset before age 65 with a positive family history of early-onset Alzheimer's disease |
|
| Disease(s) tested for: |
Alzheimer's disease |
|
| Test Details |
|
| Test Code: |
179 |
|
| Profile includes: |
ADmark® APP DNA Sequencing/Duplication Test, ADmark® PS-1 DNA Sequencing Test, ADmark® PS-2 DNA Sequencing Test
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
Yes |
|
| Special Notes: |
Athena does not perform this test for individuals under the age of 18 |
|
| Technical Information |
|
| Utility: |
Detects mutations in the PS-1, PS-2, and APP genes |
|
| Methodology: |
Polymerase Chain Reaction (PCR) and DNA sequencing |
|
| Reference Value: |
No sequence variation detected |
|
| CPT Code(s): |
83891(1), 83896(14), 83898(38), 83900(1), 83901(12), 83904(38), 83914(14), 83909(4), 83912(1) |
|
| Patents: |
6,194,153, 5,840,540 |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10 ml |
| Collection Tube: |
Lavender top (EDTA) |
|
| Storage Conditions: |
Refrigerate if necessary for a maximum of 24 hours |
|
| Shipping Conditions: |
Room temperature. Ship within 24 hours, Monday-Thursday only. |
|
| Test Turnaround: |
14-21 days |
|
|
[back to top]
|
